Researchers report encouraging results from combination therapy in Hodgkin lymphoma
Tuesday, June 6, 2017 - 14:52
in Health & Medicine
Combination therapy with brentuximab vedotin and gemcitabine in patients is “highly active" regimen for patients with Hodgkin lymphoma, the authors of a phase II clinical study report.